Aarti Drugs Limited (BOM:524348)

Aarti Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	95.7	75.61	94.32	89.6	223.3	97.79
Short-Term Investments	149.7	145.82	108.89	113.3	120.51	122.05
Cash & Short-Term Investments	245.4	221.43	203.2	202.89	343.81	219.84
Cash Growth	-16.98%	8.97%	0.15%	-40.99%	56.39%	15.31%
Accounts Receivable	7,196	7,512	7,046	8,648	7,499	5,552
Other Receivables	7.5	188.21	47.17	39.11	6.98	24.37
Receivables	7,208	7,708	7,095	8,691	7,506	5,577
Inventory	4,700	4,729	4,859	5,163	5,259	4,150
Other Current Assets	970.3	725.3	1,050	861.42	824.5	621.43
Total Current Assets	13,124	13,384	13,207	14,918	13,934	10,568
Property, Plant & Equipment	12,476	11,331	10,351	8,622	7,665	6,844
Long-Term Investments	225.4	224.13	199.74	187.99	194.8	173.01
Other Intangible Assets	99.1	631.88	368.24	243.34	1.53	2.55
Other Long-Term Assets	198.3	176.19	197.04	242.33	284.36	72.61
Total Assets	26,123	25,747	24,324	24,214	22,080	17,660
Accounts Payable	3,996	4,339	4,496	4,925	4,687	3,300
Accrued Expenses	45.6	85.95	71.78	91.65	76.77	171.92
Short-Term Debt	-	-	-	3,605	3,563	1,572
Current Portion of Long-Term Debt	2,976	3,282	2,871	412.96	435	396.08
Current Portion of Leases	10.8	11.78	9.5	19.92	25.97	27.97
Current Income Taxes Payable	-	-	11.81	42.33	-	-
Other Current Liabilities	800.1	650.14	495.39	397.13	612.7	485.77
Total Current Liabilities	7,829	8,370	7,955	9,495	9,401	5,954
Long-Term Debt	2,736	2,840	2,753	2,047	1,385	1,476
Long-Term Leases	12.4	16.51	9.14	4.03	18.79	35.8
Long-Term Unearned Revenue	1.6	1.6	1.7	1.7	1.7	1.7
Pension & Post-Retirement Benefits	43.3	43.25	27.41	30.35	28.75	18.18
Long-Term Deferred Tax Liabilities	815.4	782.33	757.07	709.68	724.31	771.34
Other Long-Term Liabilities	-0.1	-	-0	-	157.45	269.89
Total Liabilities	11,437	12,053	11,504	12,287	11,717	8,526
Common Stock	912.7	912.7	919.35	926	926	932
Retained Earnings	-	12,560	11,701	10,811	9,240	8,018
Comprehensive Income & Other	13,770	217.31	194.75	187.48	197.4	184.54
Total Common Equity	14,683	13,690	12,815	11,924	10,364	9,134
Minority Interest	2.9	3.44	4.06	2.33	-0.6	-0.17
Shareholders' Equity	14,686	13,693	12,820	11,927	10,363	9,134
Total Liabilities & Equity	26,123	25,747	24,324	24,214	22,080	17,660
Total Debt	5,735	6,151	5,643	6,089	5,428	3,508
Net Cash (Debt)	-5,490	-5,929	-5,440	-5,886	-5,084	-3,288
Net Cash Per Share	-63.11	-64.96	-59.17	-63.57	-54.91	-35.28
Filing Date Shares Outstanding	98.86	91.27	91.94	92.6	92.6	93.2
Total Common Shares Outstanding	98.86	91.27	91.94	92.6	92.6	93.2
Working Capital	5,296	5,014	5,252	5,423	4,533	4,614
Book Value Per Share	148.52	149.99	139.40	128.77	111.92	98.01
Tangible Book Value	14,584	13,058	12,447	11,681	10,362	9,132
Tangible Book Value Per Share	147.51	143.07	135.39	126.14	111.90	97.98
Land	-	948.11	937.67	937.67	934.6	649.81
Buildings	-	2,419	2,257	1,932	1,921	1,882
Machinery	-	11,463	10,633	9,122	8,792	8,383
Construction In Progress	-	2,741	2,252	1,868	767.37	192.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.